COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System

Heart Lung Circ. 2020 Nov;29(11):1596-1602. doi: 10.1016/j.hlc.2020.08.010. Epub 2020 Sep 2.

Abstract

The recently described severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people, with thousands of fatalities. It has prompted global efforts in research, with focus on the pathophysiology of coronavirus disease-19 (COVID-19), and a rapid surge of publications. COVID-19 has been associated with a myriad of clinical manifestations, including the lungs, heart, kidneys, central nervous system, gastrointestinal system, skin, and blood coagulation abnormalities. The endothelium plays a key role in organ dysfunction associated with severe infection, and current data suggest that it is also involved in SARS-CoV-2-induced sepsis. This critical review aimed to address a possible unifying mechanism underlying the diverse complications of COVID-19: microvascular dysfunction, with emphasis on the renin-angiotensin system. In addition, research perspectives are suggested in order to expand understanding of the pathophysiology of the infection.

Keywords: COVID-19; Microcirculation; Renin-angiotensin system.

Publication types

  • Review

MeSH terms

  • Betacoronavirus / physiology
  • COVID-19
  • Coronavirus Infections* / metabolism
  • Coronavirus Infections* / physiopathology
  • Humans
  • Microvessels* / metabolism
  • Microvessels* / physiopathology
  • Microvessels* / virology
  • Pandemics*
  • Pneumonia, Viral* / metabolism
  • Pneumonia, Viral* / physiopathology
  • Renin-Angiotensin System / physiology*
  • SARS-CoV-2